MedTrace Logo

Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)

NCT03994302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2023-04-13

No results posted yet for this study

Summary

Several drugs and chemotherapies seem to have an impact on the immune system. This study investigates reports of immune toxicities such as antiphospholipid syndrome, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

Conditions

  • Antiphospholipid Syndrome
  • Immune Disease
  • Adverse Drug Event
  • Drug Toxicity

Interventions

DRUG

Drug inducing antiphospholipid syndrome

Drugs susceptible to induce immune toxicities such as antiphospholipid syndrome

Sponsors & Collaborators

  • Groupe Hospitalier Pitie-Salpetriere

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-06-30
Completion
2023-04-08
FDA Drug
Yes

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03994302 on ClinicalTrials.gov